Artículo especial
Impacto de dapagliflozina en los factores de riesgo cardiovascular. Más allá del control de la glucemia
Impact of dapagliflozin on cardiovascular risk factors. Beyond glycemic control
Leído
37686
Vecesse ha leído el artículo
1513
Total PDF
36173
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 181 | 14 | 195 |
| 2025 11 | 1060 | 57 | 1117 |
| 2025 10 | 1210 | 27 | 1237 |
| 2025 9 | 1208 | 50 | 1258 |
| 2025 8 | 1089 | 46 | 1135 |
| 2025 7 | 1294 | 26 | 1320 |
| 2025 6 | 1356 | 31 | 1387 |
| 2025 5 | 2059 | 52 | 2111 |
| 2025 4 | 2248 | 66 | 2314 |
| 2025 3 | 1721 | 48 | 1769 |
| 2025 2 | 1277 | 31 | 1308 |
| 2025 1 | 1357 | 36 | 1393 |
| 2024 12 | 1066 | 34 | 1100 |
| 2024 11 | 1471 | 45 | 1516 |
| 2024 10 | 1213 | 47 | 1260 |
| 2024 9 | 1402 | 44 | 1446 |
| 2024 8 | 1419 | 44 | 1463 |
| 2024 7 | 1106 | 31 | 1137 |
| 2024 6 | 1389 | 38 | 1427 |
| 2024 5 | 1418 | 45 | 1463 |
| 2024 4 | 799 | 35 | 834 |
| 2024 3 | 878 | 40 | 918 |
| 2024 2 | 621 | 24 | 645 |
| 2024 1 | 617 | 26 | 643 |
| 2023 12 | 623 | 19 | 642 |
| 2023 11 | 1195 | 45 | 1240 |
| 2023 10 | 997 | 43 | 1040 |
| 2023 9 | 673 | 40 | 713 |
| 2023 8 | 372 | 26 | 398 |
| 2023 7 | 313 | 16 | 329 |
| 2023 6 | 684 | 25 | 709 |
| 2023 5 | 345 | 21 | 366 |
| 2023 4 | 222 | 32 | 254 |
| 2023 3 | 196 | 33 | 229 |
| 2023 2 | 142 | 32 | 174 |
| 2022 1 | 126 | 25 | 151 |
| 2022 12 | 119 | 29 | 148 |
| 2022 11 | 144 | 20 | 164 |
| 2022 10 | 144 | 20 | 164 |
| 2022 9 | 131 | 22 | 153 |
| 2022 8 | 101 | 47 | 148 |
| 2022 7 | 60 | 26 | 86 |
| 2022 6 | 72 | 16 | 88 |
| 2022 3 | 3 | 4 | 7 |
| 2022 2 | 5 | 2 | 7 |
| 2021 1 | 2 | 0 | 2 |
| 2021 12 | 45 | 22 | 67 |
| 2021 11 | 0 | 11 | 11 |
Mostrar todo
